Company Filing History:
7 out of 7 
1 out of 1 Years Active: 2016-2024
Title: Nils Carlin: Innovator in Vaccine Development
Introduction
Nils Carlin, based in Bromma, Sweden, is a prominent inventor with a remarkable portfolio of eight patents. His groundbreaking work primarily focuses on vaccine development, particularly in the realm of immunization against enterotoxigenic Escherichia coli (ETEC)-induced diarrhea, contributing significantly to public health and safety.
Latest Patents
Nils Carlin holds several innovative patents, including:
1. **Vaccine for protection against ETEC-induced diarrhea comprising dmLT** - This oral vaccine is designed for immunization against ETEC-induced diarrhea. It includes inactivated cells expressing an ETEC colonization factor antigen along with dmLT protein adjuvant, with an emphasis on comprising less than 10 cells per unit dose.
2. **Method for increasing ETEC CS6 antigen presentation on cell surface and products obtainable thereof** - This method enhances the presentation of ETEC CS6 antigen on cell surfaces. The process involves contacting cells that express this antigen with an aqueous solution containing 0.6-2.2 percent phenol by weight, resulting in an increase in antigen presentation by at least 100%.
3. **Method for the manufacture of a killed whole cell vaccine for immunization against CS6-expressing ETEC** - This patent outlines the method for creating a killed whole cell vaccine aimed at immunization against CS6-expressing ETEC, along with the cells and vaccines that can be derived from these methods.
Career Highlights
Nils Carlin has made significant strides in the field of biotechnology, particularly through his roles at Scandinavian Biopharma Holding AB and Etvax AB. His work has been pivotal in addressing the challenges posed by ETEC infections through innovative vaccine solutions.
Collaborations
Throughout his career, Nils has collaborated with esteemed colleagues such as Ann-Mari Svennerholm and Joshua Tobias. These collaborations have facilitated the advancement of his research and the development of effective vaccination strategies against ETEC-related diseases.
Conclusion
As an inventor with a fruitful track record, Nils Carlin continues to be an influential figure in vaccine research and development. His latest patents and collaborative efforts underline his commitment to combating infectious diseases and improving global health outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.